Characterization of Immunoactive and Immunotolerant CD4+ T Cells in Breast Cancer by Measuring Activity of Signaling Pathways That Determine Immune Cell Function.
Authors : Wesseling-Rozendaal Y, van Doorn A, Willard-Gallo K, van de Stolpe A Year : 2022 Journal : Cancers (Basel)
A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.
Authors : Gourari K, Catherine J, Garaud S, Kerger J, Lepida A, Georgala A, Lebrun F, Gomez Galdon M, Gil T, Willard-Gallo K, Langouo Fontsa M Year : 2022 Journal : Diagnostics (Basel)
T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy.
Authors : Garaud S, Dieu-Nosjean MC, Willard-Gallo K Year : 2022 Journal : Nat Commun
Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?
Authors : De Silva P, Aiello M, Gu-Trantien C, Migliori E, Willard-Gallo K, Solinas C Year : 2021 Journal : Int J Cancer
RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies.
Authors : van de Stolpe A, Verhaegh W, Blay JY, Ma CX, Pauwels P, Pegram M, Prenen H, De Ruysscher D, Saba NF, Slovin SF, Willard-Gallo K, Husain H Year : 2021 Journal : Front Genet